We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05%74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K
Name Holding Trade Value Shares
Change
Change in
Stake
WCM
126
Winton Capital Management
United Kingdom
$572K +$25.5K +216 +5%
MF
127
Magnetar Financial
Illinois
$569K +$571K +4,842 New
AIS
128
AlphaOne Investment Services
Pennsylvania
$555K
Barclays
129
Barclays
United Kingdom
$547K +$203K +1,725 +59%
Natixis Advisors
130
Natixis Advisors
Massachusetts
$542K -$4.95K -42 -0.9%
AG
131
Algert Global
California
$541K
Tudor Investment Corp
132
Tudor Investment Corp
Connecticut
$541K +$11.8K +100 +2%
OPERF
133
Oregon Public Employees Retirement Fund
Oregon
$508K
US Bancorp
134
US Bancorp
Minnesota
$497K -$22.5K -191 -4%
HCMT
135
Highland Capital Management (Texas)
Texas
$478K +$479K +4,062 New
MC
136
Martin & Co
Tennessee
$473K +$5.9K +50 +1%
NTCOC
137
Northern Trust Company of Connecticut
Connecticut
$470K +$59K +500 +14%
HI
138
HBK Investments
Texas
$467K +$142K +1,201 +43%
PA
139
Profund Advisors
Maryland
$463K +$150K +1,268 +48%
Arrowstreet Capital
140
Arrowstreet Capital
Massachusetts
$451K -$1.8M -15,231 -80%
URS
141
Utah Retirement Systems
Utah
$443K
Citigroup
142
Citigroup
New York
$430K -$157K -1,333 -27%
PAM
143
Panagora Asset Management
Massachusetts
$416K
GCP
144
GSA Capital Partners
United Kingdom
$400K +$177K +1,500 +79%
ZIM
145
Zacks Investment Management
Illinois
$394K -$157K -1,329 -28%
MERSOM
146
Municipal Employees' Retirement System of Michigan
Michigan
$388K +$389K +3,300 New
AIP
147
Ameritas Investment Partners
Nebraska
$370K +$371K +3,146 New
ACI
148
Advance Capital I
Michigan
$364K
SPC
149
Stewart & Patten Company
California
$363K
SAM
150
Securian Asset Management
Minnesota
$350K -$14.7K -125 -4%

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.